Macau, China vs Syrian Arab Republic: Tuberculosis patients living with HIV receiving antiretroviral therapy

Macau, China
3 patients
in 2021
Syrian Arab Republic
3 patients
in 2021
Macau, China rank
117th
Syrian Arab Republic rank
117th

Tuberculosis patients living with HIV receiving antiretroviral therapy over time

  • Macau, China
  • Syrian Arab Republic
02468200320122021

How they compare

Macau, China currently reports 3 patients against 3 patients in Syrian Arab Republic, a difference of 0 patients.

The two have swapped places 15 times across 19 shared years of data; in 2003 it was Macau, China ahead.

Macau, China ranks 117th and Syrian Arab Republic ranks 117th of 183 countries.

Macau, China has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade Macau, China Syrian Arab Republic Difference Ahead
2000s 0.5714 patients 0 patients 0.5714 patients Macau, China
2010s 1.8 patients 1.6 patients 0.2 patients Macau, China
2020s 2.5 patients 2 patients 0.5 patients Macau, China

Averages of every year both report within each decade.

Frequently asked questions

Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Macau, China or Syrian Arab Republic?
Macau, China, at 3 patients against 3 patients in Syrian Arab Republic as of 2021.
What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Macau, China and Syrian Arab Republic?
0 patients, with Macau, China ahead.
How many years of comparable data are there for Macau, China and Syrian Arab Republic?
19 years are reported by both, from 2003 to 2021.
How do Macau, China and Syrian Arab Republic rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
Macau, China ranks 117th and Syrian Arab Republic ranks 117th of 183 countries.
Where does this data come from?
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Macau, China vs Syrian Arab Republic: Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid, drawing on Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data. Retrieved 14 September 2026, from https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/macao-sar-china/syrian-arab-republic/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (Our World in Data); please keep the attribution.

<a href="https://health.statizoid.com/compare/tb-patients-living-with-hiv-receiving-art/macao-sar-china/syrian-arab-republic/">Macau, China vs Syrian Arab Republic: Tuberculosis patients living with HIV receiving antiretroviral therapy</a> — Statizoid

About this data

Indicator
Tuberculosis patients living with HIV receiving antiretroviral therapy
Unit
patients
Source
Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data
Licence
CC BY 4.0 (Our World in Data)
Coverage
183 places, 2,780 data points, 2000–2021
Last refreshed

Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.